logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

VITASOY INT'L (00345) repurchased 116,000 shares for HKD 788,800 on October 14.

date
14/10/2026
Zhito Finance APP news, VITASOY INT'L (00345) announced that on October 14, 2026, the company spent HK$788,800 to repurchase 116,000 shares at a repurchase price of HK$6.795-6.8 per share.
Latest
1 m ago
AInnovation (02121.HK) repurchased 269,100 shares for HKD 947,700 on October 14.
1 m ago
Basic Semiconductor (09971.HK) repurchased 40,000 shares for approximately HK$1.3866 million on October 14.
3 m ago
Southbound capital recorded a net sell of HKD 135 million today.
3 m ago
Walvax Biotechnology: The freeze-dried herpes zoster virus mRNA vaccine has officially launched Phase I clinical trials.
3 m ago
Wushang Group: The shareholding ratio of the largest shareholder and its concerted parties increased to 28.24%.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.